Literature DB >> 11114736

Ligand discrimination by ErbB receptors: differential signaling through differential phosphorylation site usage.

C Sweeney1, K L Carraway.   

Abstract

The four members of the ErbB family of receptor tyrosine kinases (RTKs) mediate a variety of cellular responses to epidermal growth factor (EGF)-like growth factors, and serve as a model for the generation of both diversity and specificity in RTK signaling. Previous studies indicate that receptor-receptor interactions figure prominently in signaling through ErbB receptors. In addition to a role in receptor kinase activation, ligand-induced ErbB receptor homo- and heterodimerization is thought to account for the diversity of biological responses stimulated by EGF-like growth factors. Since each receptor has the potential to couple to different complements of signaling pathways, EGF-like ligands specify cellular response by dictating which pairs of receptors become activated. More recently evidence has been uncovered for ligand discrimination by individual ErbB receptor dimers; receptors appear to realize which ligand is binding and differentially respond through autophosphorylation site usage. These observations indicate that ligand stimulation of RTKs is not generic, and point to another layer in the ErbB signal diversification mechanism. The mechanistic implications of ligand discrimination are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11114736     DOI: 10.1038/sj.onc.1203913

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  30 in total

1.  Zinc finger transcription factors designed for bispecific coregulation of ErbB2 and ErbB3 receptors: insights into ErbB receptor biology.

Authors:  Caren V Lund; Mikhail Popkov; Laurent Magnenat; Carlos F Barbas
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

Review 2.  Structure, evolution, and biology of the MUC4 mucin.

Authors:  Pallavi Chaturvedi; Ajay P Singh; Surinder K Batra
Journal:  FASEB J       Date:  2007-11-16       Impact factor: 5.191

3.  Cancer: A shocking protein complex.

Authors:  Kai Bartkowiak; Klaus Pantel
Journal:  Nature       Date:  2016-10-05       Impact factor: 49.962

4.  Prediction of functional phosphorylation sites by incorporating evolutionary information.

Authors:  Shen Niu; Zhen Wang; Dongya Ge; Guoqing Zhang; Yixue Li
Journal:  Protein Cell       Date:  2012-07-16       Impact factor: 14.870

Review 5.  Signalling between microvascular endothelium and cardiomyocytes through neuregulin.

Authors:  Emily M Parodi; Bernhard Kuhn
Journal:  Cardiovasc Res       Date:  2014-01-29       Impact factor: 10.787

6.  Regulation of early Xenopus development by ErbB signaling.

Authors:  Shuyi Nie; Chenbei Chang
Journal:  Dev Dyn       Date:  2006-02       Impact factor: 3.780

7.  Antibodies and Tyrosine Kinase Inhibitors in Breast Cancer Therapies.

Authors:  J Barth; Christian Jackisch; Michael Untch
Journal:  Breast Care (Basel)       Date:  2009-02-20       Impact factor: 2.860

8.  Phosphorylation-Dependent Conformations of the Disordered Carboxyl-Terminus Domain in the Epidermal Growth Factor Receptor.

Authors:  Raju Regmi; Shwetha Srinivasan; Andrew P Latham; Vandna Kukshal; Weidong Cui; Bin Zhang; Ron Bose; Gabriela S Schlau-Cohen
Journal:  J Phys Chem Lett       Date:  2020-11-12       Impact factor: 6.475

Review 9.  The ERBB3 receptor in cancer and cancer gene therapy.

Authors:  G Sithanandam; L M Anderson
Journal:  Cancer Gene Ther       Date:  2008-04-11       Impact factor: 5.987

10.  Hepatocyte growth factor-mediated renal epithelial branching morphogenesis is regulated by glypican-4 expression.

Authors:  Anil Karihaloo; Sujata Kale; Norman D Rosenblum; Lloyd G Cantley
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.